Your browser doesn't support javascript.
loading
A combination of fecal calprotectin and human beta-defensin 2 facilitates diagnosis and monitoring of inflammatory bowel disease.
Gacesa, R; Vich Vila, A; Collij, V; Mujagic, Z; Kurilshikov, A; Voskuil, M D; Festen, E A M; Wijmenga, C; Jonkers, D M A E; Dijkstra, G; Fu, J; Zhernakova, A; Imhann, F; Weersma, R K.
Afiliação
  • Gacesa R; University of Groningen, University Medical Center Groningen, Department of Gastroenterology and Hepatology, Groningen, The Netherlands.
  • Vich Vila A; University of Groningen and University Medical Center Groningen, Department of Genetics, Groningen, The Netherlands.
  • Collij V; University of Groningen, University Medical Center Groningen, Department of Gastroenterology and Hepatology, Groningen, The Netherlands.
  • Mujagic Z; University of Groningen and University Medical Center Groningen, Department of Genetics, Groningen, The Netherlands.
  • Kurilshikov A; University of Groningen, University Medical Center Groningen, Department of Gastroenterology and Hepatology, Groningen, The Netherlands.
  • Voskuil MD; University of Groningen and University Medical Center Groningen, Department of Genetics, Groningen, The Netherlands.
  • Festen EAM; Maastricht University Medical Center, Division of Gastroenterology-Hepatology, NUTRIM School for Nutrition and Translational Research in Metabolism, Maastricht, The Netherlands.
  • Wijmenga C; University of Groningen and University Medical Center Groningen, Department of Genetics, Groningen, The Netherlands.
  • Jonkers DMAE; University of Groningen, University Medical Center Groningen, Department of Gastroenterology and Hepatology, Groningen, The Netherlands.
  • Dijkstra G; University of Groningen and University Medical Center Groningen, Department of Genetics, Groningen, The Netherlands.
  • Fu J; University of Groningen, University Medical Center Groningen, Department of Gastroenterology and Hepatology, Groningen, The Netherlands.
  • Zhernakova A; University of Groningen and University Medical Center Groningen, Department of Genetics, Groningen, The Netherlands.
  • Imhann F; University of Groningen and University Medical Center Groningen, Department of Genetics, Groningen, The Netherlands.
  • Weersma RK; Maastricht University Medical Center, Division of Gastroenterology-Hepatology, NUTRIM School for Nutrition and Translational Research in Metabolism, Maastricht, The Netherlands.
Gut Microbes ; 13(1): 1943288, 2021.
Article em En | MEDLINE | ID: mdl-34313538
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Inflamatórias Intestinais / Beta-Defensinas / Complexo Antígeno L1 Leucocitário / Síndrome do Intestino Irritável / Fezes / Microbioma Gastrointestinal Tipo de estudo: Diagnostic_studies / Etiology_studies / Guideline / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Gut Microbes Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Holanda
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Inflamatórias Intestinais / Beta-Defensinas / Complexo Antígeno L1 Leucocitário / Síndrome do Intestino Irritável / Fezes / Microbioma Gastrointestinal Tipo de estudo: Diagnostic_studies / Etiology_studies / Guideline / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Gut Microbes Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Holanda